{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:11:53Z","timestamp":1785190313611,"version":"3.55.0"},"reference-count":205,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Community's Seventh Framework Programme"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.atherosclerosis.2013.10.030","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T16:46:04Z","timestamp":1383756364000},"page":"99-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"title":["Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology"],"prefix":"10.1016","volume":"232","author":[{"given":"P.","family":"Loria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Marchesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Nascimbeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1424-7894","authenticated-orcid":false,"given":"S.","family":"Ballestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maurantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Carubbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ratziu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lonardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1055\/s-2008-1040406","article-title":"Hepatic synthesis of lipoproteins and apolipoproteins","volume":"12","author":"Dixon","year":"1992","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pharmthera.2003.10.001","article-title":"Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia","volume":"101","author":"Le Goff","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.atherosclerosis.2010.04.025","article-title":"LXRalpha regulates human CETP expression in\u00a0vitro and in transgenic mice","volume":"212","author":"Honzumi","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1476-511X-10-156","article-title":"The role of common variants of the cholesteryl ester transfer protein gene in left main coronary artery disease","volume":"10","author":"Kolovou","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.atherosclerosis.2009.11.011","article-title":"Influence of menopause and cholesteryl ester transfer protein (CETP) TaqIB polymorphism on lipid profile and HDL subpopulations distribution in women with and without type 2 diabetes","volume":"210","author":"Russo","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib6","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1001\/jama.299.23.2777","article-title":"Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk","volume":"299","author":"Thompson","year":"2008","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/01.ATV.20.1.189","article-title":"Action of atorvastatin in combined hyperlipidemia: preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles","volume":"20","author":"Guerin","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib8","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/hep.22402","article-title":"Statins in liver disease: a molehill, an iceberg, or neither?","volume":"48","author":"Argo","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib9","unstructured":"http:\/\/www.nhlbi.nih.gov\/guidelines\/cholesterol\/atp4\/index.htm."},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib10","first-page":"33","article-title":"Non-alcoholic fatty liver disease (NAFLD): a novel cardiovascular risk factor","volume":"7","author":"Ballestri","year":"2012","journal-title":"Intern Emerg Med Suppl"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib11","first-page":"25","article-title":"Hepatitis C and cardiovascular risk: facts and controversies","volume":"8","author":"Lonardo","year":"2012","journal-title":"Hot Top Viral Hepat"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0140-6736(72)91552-8","article-title":"Clinical and metabolic study of alcoholic hyperlipemia","volume":"2","author":"Chait","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.amjcard.2012.04.062","article-title":"Secondary causes of dyslipidemia","volume":"1110","author":"Vodnala","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib14","first-page":"371","article-title":"Effects of a moderate dose of alcohol on blood lipids and lipoproteins postprandially and in the fasting state","volume":"25","author":"Veenstra","year":"1990","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0022-2275(20)40613-3","article-title":"Effects of ethanol on lipid metabolism","volume":"20","author":"Baraona","year":"1979","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib16","series-title":"Recent developments in alcoholism","first-page":"97","article-title":"Alcohol and lipids","author":"Baraona","year":"1998"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/alcalc\/agq088","article-title":"Severe hypertriglyceridemia influenced by alcohol (SHIBA)","volume":"46","author":"Bessembinders","year":"2011","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib18","first-page":"4","article-title":"The effect of alcohol on postprandial and fasting triglycerides","volume":"2012","author":"Van de Wiel","year":"2012","journal-title":"Int J Vasc Med"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0026-0495(89)90257-6","article-title":"Short-term effects of moderate alcohol consumption on lipid metabolism and energy balance in normal men","volume":"38","author":"Contaldo","year":"1989","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pathophys.2003.10.009","article-title":"Effects of ethanol on lipids and atherosclerosis","volume":"10","author":"Hannuksela","year":"2004","journal-title":"Pathophysiology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0022-2275(20)38119-0","article-title":"Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of \u201clight\u201d-HDL during partial recovery","volume":"23","author":"Weidman","year":"1982","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/hep.1840030311","article-title":"High-density lipoprotein cholesterol and liver disease","volume":"3","author":"Kanel","year":"1983","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib23","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0016-5085(77)80267-9","article-title":"Abnormal plasma lipoproteins and lecithin-cholesterol acyltransferase deficiency in alcoholic liver disease","volume":"2","author":"Sabesin","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/BF01487639","article-title":"Serum lipids and total fatty acids in chronic alcoholic liver disease at different stages of cell damage","volume":"48","author":"Marzo","year":"1970","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF02533630","article-title":"Hepatic triglyceride lipase deficiency in liver disease","volume":"12","author":"Freeman","year":"1977","journal-title":"Lipids"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib26","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/clinchem\/42.10.1666","article-title":"Changes in serum apolipoprotein and lipoprotein profile induced by chronic alcohol consumption and withdrawal: determinant effect on heart disease?","volume":"42","author":"Lecomte","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib27","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1073\/pnas.82.6.1815","article-title":"Abnormal polyunsaturated fatty acid patterns of serum lipids in alcoholism and cirrhosis: arachidonic acid deficiency in cirrhosis","volume":"82","author":"Johnson","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3164\/jcbn.12-79","article-title":"Abnormalities in the serum phospholipids fatty acid profile in patients with alcoholic liver cirrhosis - a pilot study","volume":"53","author":"Risti\u0107-Medi\u0107","year":"2013","journal-title":"J\u00a0Clin Biochem Nutr"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib29","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1002\/hep.20957","article-title":"Alcohol and oxidative liver injury","volume":"43","author":"Dey","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib30","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/ajcn\/70.5.928","article-title":"De novo lipogenesis, lipid kinetics, and whole-body lipid balances in humans after acute alcohol consumption","volume":"70","author":"Siler","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib31","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1152\/ajpendo.00011.2008","article-title":"Alcohol and lipid metabolism","volume":"295","author":"Sozio","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib32","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0024-3205(00)01035-3","article-title":"Chronic ingestion of ethanol stimulates lipogenic response in rat hepatocytes","volume":"68","author":"Carrasco","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jhep.2008.04.026","article-title":"Fish oil fed prior to ethanol administration prevents acute ethanol-induced fatty liver in mice","volume":"49","author":"Wada","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib34","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1530-0277.2008.00892.x","article-title":"Quantitative lipid metabolomic changes in alcoholic micropigs with fatty liver disease","volume":"33","author":"Zivkovic","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib35","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.freeradbiomed.2012.06.029","article-title":"Cytochrome P4502E1, oxidative stress, JNK, and autophagy in acute alcohol-induced fatty liver","volume":"53","author":"Yang","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib36","doi-asserted-by":"crossref","first-page":"e55382","DOI":"10.1371\/journal.pone.0055382","article-title":"Chronic alcohol exposure disturbs lipid homeostasis at the adipose tissue-liver axis in mice: analysis of triacylglycerols using high-resolution mass spectrometry in combination with in\u00a0vivo metabolite deuterium labeling","volume":"8","author":"Wei","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib37","first-page":"489","article-title":"Evaluation of coagulation parameters and liver enzymes among alcohol drinkers in Port Harcourt, Nigeria","volume":"6","author":"Adias","year":"2013","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib38","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jhep.2007.12.015","article-title":"Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease","volume":"48","author":"Seth","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib39","doi-asserted-by":"crossref","first-page":"f11","DOI":"10.1136\/bmj.f11","article-title":"Investigating an incidental finding of thrombocytopenia","volume":"346","author":"Bradbury","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib40","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1172\/JCI5584","article-title":"Alcohol-induced generation of lipid peroxidation products in humans","volume":"104","author":"Meagher","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib41","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s11883-012-0266-8","article-title":"Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease","volume":"14","author":"Chen","year":"2012","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib42","doi-asserted-by":"crossref","first-page":"e56803","DOI":"10.1371\/journal.pone.0056803","article-title":"Effect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-analysis of randomized controlled trials","volume":"8","author":"Ye","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib43","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/MOL.0b013e32833c1f41","article-title":"Effects of ethanol intake on lipoproteins and atherosclerosis","volume":"21","author":"Brinton","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/alcalc\/agp092","article-title":"Alcohol intake and systemic markers of inflammation \u2013 shape of the association according to sex and body mass index","volume":"45","author":"Oliveira","year":"2010","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib45","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1161\/01.CIR.94.11.3023","article-title":"Alcohol and heart disease","volume":"94","author":"Pearson","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib46","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.amjcard.2008.09.089","article-title":"Alcohol drinking and cardiovascular risk in a population with high mean alcohol consumption","volume":"103","author":"Foerster","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib47","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.atherosclerosis.2008.10.036","article-title":"Alcohol consumption and the prevalence of metabolic syndrome: a meta-analysis of observational studies","volume":"204","author":"Alkerwi","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib48","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1136\/bmj.319.7224.1523","article-title":"Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors","volume":"319","author":"Rimm","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib49","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.dld.2010.01.021","article-title":"Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee","volume":"42","author":"Loria","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib50","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2337\/dc09-0227","article-title":"Alcohol as a risk factor for type 2 diabetes: a systematic review and meta-analysis","volume":"32","author":"Baliunas","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib51","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3748\/wjg.15.280","article-title":"Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management","volume":"15","author":"Garcia-Compean","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib52","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1210\/jc.2007-0334","article-title":"Insulin resistance, insulin response, and obesity as indicators of metabolic risk","volume":"92","author":"Ferrannini","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib53","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0026-0495(00)80002-5","article-title":"Impact of insulin resistance on lipoprotein subpopulation distribution in lean and morbidly obese nondiabetic women","volume":"49","author":"MacLean","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib55","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2013.01.022","article-title":"Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis","volume":"227","author":"Defilippis","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0032-1306423","article-title":"Dyslipidemia in patients with nonalcoholic fatty liver disease","volume":"32","author":"Chatrath","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib57","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib58","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ecl.2004.03.016","article-title":"Metabolic abnormalities: triglyceride and low-density lipoprotein","volume":"33","author":"Krauss","year":"2004","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib59","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00125-005-0125-z","article-title":"Overproduction of large VLDL particles is driven by increased liver fat content in man","volume":"49","author":"Adiels","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib60","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jhep.2005.06.018","article-title":"Hepatic steatosis and insulin resistance: does etiology make a difference?","volume":"44","author":"Lonardo","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib61","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/01.ATV.0000176191.64314.07","article-title":"Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia","volume":"25","author":"Sankatsing","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib62","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2010.03.039","article-title":"Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia","volume":"139","author":"Amaro","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib63","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s00125-011-2157-x","article-title":"Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia","volume":"54","author":"Visser","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib64","doi-asserted-by":"crossref","first-page":"16381","DOI":"10.1073\/pnas.1113359108","article-title":"Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease","volume":"108","author":"Kumashiro","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib65","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.dld.2010.01.016","article-title":"From the metabolic syndrome to NAFLD or vice versa?","volume":"42","author":"Vanni","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/ATVBAHA.107.147538","article-title":"Fatty liver: a novel component of the metabolic syndrome","volume":"28","author":"Kotronen","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20070311","article-title":"Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis","volume":"115","author":"Loria","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib68","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/01.ATV.0000154144.73236.f4","article-title":"Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Qu\u00e9bec Cardiovascular Study","volume":"25","author":"St-Pierre","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib69","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/MOL.0b013e32833ea9ec","article-title":"Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus","volume":"21","author":"Brouwers","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib70","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2012.15","article-title":"The genetics of familial combined hyperlipidaemia","volume":"8","author":"Brouwers","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib71","first-page":"11","article-title":"Nonalcoholic fatty liver disease","volume":"2","author":"Yu","year":"2002","journal-title":"Rev Gastroenterol Disord"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib72","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.2174\/1381612811319290003","article-title":"Cardiovascular and systemic risk in nonalcoholic fatty liver disease -atherosclerosis as a major player in the natural course of NAFLD","volume":"19","author":"Lonardo","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib73","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1007\/s10620-009-1075-y","article-title":"The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk","volume":"55","author":"Alkhouri","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib74","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/hep.25739","article-title":"Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism","volume":"56","author":"Musso","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib75","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.23129","article-title":"Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss","volume":"50","author":"Johnson","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib76","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib77","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jhep.2011.06.010","article-title":"Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review","volume":"56","author":"Thoma","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib78","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.clinre.2012.10.009","article-title":"Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD)","volume":"37","author":"Scaglioni","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib79","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib80","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s10620-012-2118-3","article-title":"Lipid-lowering agents in nonalcoholic fatty liver disease and steatohepatitis: human studies","volume":"57","author":"Nseir","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib81","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1111\/j.1440-1746.2012.07232.x","article-title":"Potential for statins in the chemoprevention and management of hepatocellular carcinoma","volume":"27","author":"Lonardo","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib82","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.dld.2012.02.020","article-title":"If steatosis is the atherosclerosis of the liver, are statins the \u201caspirin\u201d for steatosis?","volume":"44","author":"Lonardo","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib83","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1002\/hep.24042","article-title":"Therapeutic trials in nonalcoholic steatohepatitis: insulin sensitizers and related methodological issues","volume":"52","author":"Ratziu","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib84","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1586\/egh.11.19","article-title":"Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies?","volume":"5","author":"Lonardo","year":"2011","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib85","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/eurheartj\/ehs084","article-title":"Antisense oligonucleotides for the treatment of dyslipidaemia","volume":"33","author":"Visser","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib86","first-page":"1173","article-title":"Changes in serum lipids and lipoproteins in acute hepatitis","volume":"106","author":"Mordasini","year":"1976","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib87","first-page":"564","article-title":"Moderate hypertriglyceridemia following acute hepatitis B","volume":"107","author":"Moorjani","year":"1978","journal-title":"Union Med Can"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib88","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.metabol.2012.07.022","article-title":"Combined effects of hepatitis B virus infection and elevated alanine aminotransferase levels on dyslipidemia","volume":"62","author":"Liu","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib89","first-page":"286","article-title":"Chronic hepatitis B virus infection and dyslipidemia","volume":"103","author":"Su","year":"2004","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib90","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1111\/j.1365-2893.2011.01535.x","article-title":"Impact of hepatitis B virus infection on metabolic profiles and modifying factors","volume":"19","author":"Hsu","year":"2012","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib91","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jhep.2011.09.013","article-title":"Hepatitis B virus infection and fatty liver in the general population","volume":"56","author":"Wong","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib92","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1440-1746.2007.05216.x","article-title":"Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis","volume":"23","author":"Wang","year":"2008","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib93","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/sj.ijo.0803204","article-title":"A\u00a0population-based study investigating the association between metabolic syndrome and hepatitis B\/C infection (Keelung Community-based Integrated Screening study No. 10)","volume":"30","author":"Jan","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib94","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.atherosclerosis.2010.03.008","article-title":"Chronic hepatitis B infection and risk of atherosclerosis-related mortality: a 17-year follow-up study based on 22,472 residents in Taiwan","volume":"211","author":"Wang","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib95","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/infdis\/jis385","article-title":"Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study","volume":"206","author":"Lee","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib96","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2003.11.020","article-title":"Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease","volume":"126","author":"Lonardo","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib97","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1440-1746.2011.06801.x","article-title":"Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients","volume":"26","author":"Machado","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib98","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1586\/egh.13.7","article-title":"The predictive value of steatosis in hepatitis C virus infection","volume":"7","author":"Adinolfi","year":"2013","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib99","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.ijo.0803479","article-title":"Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?","volume":"31","author":"Chu","year":"2007","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib100","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10620-012-2343-9","article-title":"Clinical and virological characteristics post HBsAg seroclearance in hepatitis B virus carriers with hepatic steatosis versus those without","volume":"58","author":"Chu","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib101","doi-asserted-by":"crossref","first-page":"454","DOI":"10.4103\/0377-4929.85074","article-title":"Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters","volume":"54","author":"Rastogi","year":"2011","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib102","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1111\/j.1440-1746.2012.07268.x","article-title":"Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model","volume":"27","author":"Zhang","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib103","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/hep.1840360706","article-title":"Natural history of chronic hepatitis C","volume":"36","author":"Seeff","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib104","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib105","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1007\/s11739-012-0825-6","article-title":"The hepatitis C virus infection as a systemic disease","volume":"7","author":"Zignego","year":"2012","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib106","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/2009\/369703","article-title":"Hepatitis C virus-infected patients are \u2018spared\u2019 from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis","volume":"23","author":"Lonardo","year":"2009","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib107","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1517\/14656566.2011.597742","article-title":"Metabolic alterations and chronic hepatitis C: treatment strategies","volume":"12","author":"Adinolfi","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib108","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.25631","article-title":"Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner","volume":"56","author":"Clark","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib109","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00281-012-0356-2","article-title":"Lipids and HCV","volume":"35","author":"Bassendine","year":"2013","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.biochi.2012.07.016","article-title":"Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies","volume":"95","author":"Blaising","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib111","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2893.2005.00669.x","article-title":"Hepatitis C and steatosis: a reappraisal","volume":"13","author":"Lonardo","year":"2006","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib112","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2893.2011.01555.x","article-title":"Steatosis is the predictor of relapse in HCV genotype 3- but not 2-infected patients treated with 12 weeks of pegylated interferon-\u03b1-2a plus ribavirin and RVR","volume":"19","author":"Restivo","year":"2012","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib113","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1053\/j.gastro.2010.08.055","article-title":"Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C","volume":"140","author":"Rao","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib114","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1586\/eri.09.3","article-title":"Hepatitis C and diabetes: the inevitable coincidence?","volume":"7","author":"Lonardo","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1872-034X.2012.01031.x","article-title":"Liver and diabetes. A vicious circle","volume":"43","author":"Loria","year":"2013","journal-title":"Hepatol Res"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib116","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2008.08.006","article-title":"Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis","volume":"49","author":"White","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib117","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/hep.22703","article-title":"Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C","volume":"49","author":"Arase","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib118","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jhep.2007.11.022","article-title":"Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C","volume":"48","author":"Romero-G\u00f3mez","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib119","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/hrt.2003.018937","article-title":"Evidence for association between hepatitis C virus seropositivity and coronary artery disease","volume":"90","author":"Vassalle","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib120","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1253\/circj.CJ-08-0459","article-title":"Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon severity score system","volume":"72","author":"Alyan","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib121","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/gut.2009.202317","article-title":"Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors","volume":"59","author":"Mostafa","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib122","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00535-012-0610-3","article-title":"Chronic HCV infection was associated with severe insulin resistance and mild atherosclerosis: a population-based study in an HCV hyperendemic area","volume":"48","author":"Miyajima","year":"2013","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib123","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.25508","article-title":"Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations","volume":"55","author":"Petta","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib124","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2012.01.051","article-title":"Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis","volume":"221","author":"Adinolfi","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib125","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/hep.20664","article-title":"Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients","volume":"41","author":"Adinolfi","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib126","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1365-2036.2006.03114.x","article-title":"Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin\/tumour necrosis factor-alpha in chronic hepatitis C patients","volume":"24","author":"Durante-Mangoni","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib127","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijcard.2011.07.016","article-title":"Effects of hepatitis C virus on cardiovascular risk in infected patients: a comparative study","volume":"164","author":"Oliveira","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib128","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib129","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.19.6.526","article-title":"Plasma lipids and lipoproteins in liver disease","volume":"19","author":"McIntyre","year":"1978","journal-title":"Gut"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0009-8981(81)90245-X","article-title":"Serum apoprotein A-I and A-II levels in liver diseases and cholestasis","volume":"115","author":"Fujii","year":"1981","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib131","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0009-8981(84)90312-7","article-title":"A-II and B in chronic active hepatitis and in liver cirrhotic patients","volume":"137","author":"Cordova","year":"1984","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib132","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF02774648","article-title":"Alterations in levels of apolipoprotein C-III and C-II\/C-III ratios in patients with liver disease","volume":"19","author":"Koga","year":"1984","journal-title":"Gastroenterol Jpn"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib133","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/bmj.304.6826.545","article-title":"Lipoprotein(a) in cirrhosis","volume":"304","author":"Feely","year":"1992","journal-title":"Br Med J"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib134","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0009-8981(95)06251-3","article-title":"Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids","volume":"248","author":"Iglesias","year":"1996","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib135","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archinte.1997.00440280120012","article-title":"Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis","volume":"157","author":"Cicognani","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib136","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1590\/S0100-879X1997001100004","article-title":"Apolipoprotein and lipid abnormalities in chronic liver failure","volume":"30","author":"Sp\u00f3sito","year":"1997","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib137","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MEG.0b013e3280be5ac8","article-title":"Lipoprotein profile in cirrhosis of liver","volume":"19","author":"Varghese","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib138","first-page":"442","article-title":"Differential diagnosis between hepatic cirrhosis and chronic active hepatitis: specificity and sensitivity of physical and laboratory findings in a series from the Mediterranean area","volume":"78","author":"Cozzolino","year":"1983","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib139","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/00365529850172593","article-title":"Prognostic value of progressive decrease in serum cholesterol in predicting survival in child-pugh C viral cirrhosis","volume":"33","author":"D'Arienzo","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib140","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.24491","article-title":"The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study","volume":"54","author":"Bhala","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib141","first-page":"484","article-title":"Serum cholesterol: could it be a sixth parameter of Child-Pugh scoring system in cirrhotics due to viral hepatitis?","volume":"22","author":"Abbasi","year":"2012","journal-title":"J\u00a0Coll Physicians Surg Pak"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib142","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1159\/000339206","article-title":"Lipid serum profile in patients with viral liver cirrhosis","volume":"21","author":"Vere","year":"2012","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib143","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1042\/cs0560575","article-title":"Lecithin-cholesterol acyltransferase and lipoprotein abnormalities of parenchymal liver disease","volume":"56","author":"Day","year":"1979","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib144","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0026-0495(93)90166-L","article-title":"Lecithin-cholesterol acyltransferase and lipid transfer protein activities in liver disease","volume":"42","author":"Tahara","year":"1993","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib145","doi-asserted-by":"crossref","first-page":"48938","DOI":"10.1074\/jbc.M209128200","article-title":"Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein","volume":"277","author":"van Haperen","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib146","doi-asserted-by":"crossref","first-page":"31850","DOI":"10.1074\/jbc.M205077200","article-title":"Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E","volume":"277","author":"Jiang","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib147","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1194\/jlr.M800414-JLR200","article-title":"PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene Study","volume":"50","author":"Schlitt","year":"2009","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib148","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jhep.2006.11.020","article-title":"Hepatic gene expression and lipid parameters in complement C3(\u2212\/\u2212) mice that do not develop ethanol-induced steatosis","volume":"46","author":"Bykov","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib149","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jhep.2008.05.024","article-title":"Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies","volume":"49","author":"Kadayifci","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib150","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10620-009-0738-z","article-title":"Coronary artery disease in patients with liver cirrhosis","volume":"55","author":"Kalaitzakis","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib151","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0002-8703(60)90192-7","article-title":"The low incidence of myocardial infarction in patients with portal cirrhosis of the liver: a review of 639 cases of cirrhosis of the liver from 17,731 autopsies","volume":"60","author":"Howell","year":"1960","journal-title":"Am Heart J"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib152","first-page":"567","article-title":"Atherosclerosis and cirrhosis of the liver","volume":"53","author":"Van\u0115cek","year":"1976","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib153","first-page":"655","article-title":"Cardiovascular disease in cirrhosis a point-prevalence study in relation to glucose tolerance","volume":"94","author":"Marchesini","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib154","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1478-3231.2005.01002.x","article-title":"Reduced prevalence of ischemic events and abnormal supraortic flow patterns in patients with liver cirrhosis","volume":"25","author":"Berzigotti","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib155","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.3748\/wjg.15.2960","article-title":"Systemic abnormalities in liver disease","volume":"15","author":"Minemura","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib156","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1161\/01.ATV.0000217910.90210.99","article-title":"Human lecithin:cholesterol acyltransferase deficiency: in\u00a0vivo kinetics of low-density lipoprotein and lipoprotein-X","volume":"26","author":"Nishiwaki","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib157","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1476-511X-9-46","article-title":"Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment","volume":"9","author":"Marsillach","year":"2010","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib158","first-page":"185","article-title":"Abnormalities of glucose metabolism induced by liver cirrhosis and glycosylated hemoglobin levels in chronic liver disease","volume":"7","author":"Cacciatore","year":"1988","journal-title":"Diabetes Res"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib159","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1097\/00007890-200006150-00043","article-title":"Liver transplantation improves cirrhosis-associated impaired oral glucose tolerance","volume":"69","author":"Shetty","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib160","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0168-8278(00)80065-3","article-title":"Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease","volume":"32","author":"Zein","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib161","first-page":"119","article-title":"Prognostic significance of diabetes in patients with cirrhosis","volume":"20","author":"Bianchi","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib162","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/lt.23508","article-title":"Is liver transplantation a risk factor for cardiovascular disease? A meta-analysis of observational studies","volume":"18","author":"Madhwal","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib163","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/lt.22468","article-title":"Cumulative risk of cardiovascular events after orthotopic liver transplantation","volume":"18","author":"Albeldawi","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib164","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"American association for study of liver diseases. Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib165","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1053\/gast.2003.1240854","article-title":"Hypercholesterolemia in primary biliary cirrhosis: getting to the heart of the matter?","volume":"124","author":"Chauhan","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib166","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.atherosclerosis.2006.11.036","article-title":"Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review","volume":"194","author":"Sorokin","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib167","first-page":"89","article-title":"Metabolism of cholesterol and low- and high-density lipoproteins in primary biliary cirrhosis: cholesterol absorption and synthesis related to lipoprotein levels and their kinetics","volume":"21","author":"Gylling","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib168","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/gut.51.2.265","article-title":"Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis","volume":"51","author":"Longo","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib169","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1194\/jlr.M400229-JLR200","article-title":"Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation","volume":"45","author":"Chang","year":"2004","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib170","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","article-title":"Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years","volume":"123","author":"Prince","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib171","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/hep.21795","article-title":"Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study","volume":"46","author":"Jackson","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib172","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.1840150518","article-title":"Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?","volume":"15","author":"Crippin","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib173","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/00365529709025067","article-title":"Primary biliary cirrhosis in The Netherlands. An analysis of associated diseases, cardiovascular risk, and malignancies on the basis of mortality figures","volume":"32","author":"Van Dam","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib174","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1111\/j.1572-0241.2008.02092.x","article-title":"Risk of cardiovascular and cerebrovascular events in primary biliary cirrhosis: a population-based cohort study","volume":"103","author":"Solaymani-Dodaran","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib175","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4254\/wjh.v3.i4.93","article-title":"Asymptomatic primary biliary cirrhosis is not associated with increased frequency of cardiovascular disease","volume":"3","author":"Doycheva","year":"2011","journal-title":"World J Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib176","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF01307562","article-title":"Hypercholesterolemia in primary biliary cirrhosis is no risk factor for atherosclerosis","volume":"38","author":"Propst","year":"1993","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib177","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1136\/gut.2005.079814","article-title":"Hypercholesterolemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis","volume":"55","author":"Allocca","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib178","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMc071467","article-title":"Hypercholesterolemia in primary biliary cirrhosis","volume":"357","author":"Su","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib179","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1872-034X.2010.00717.x","article-title":"Primary biliary cirrhosis is associated with oxidative stress and endothelial dysfunction but not increased cardiovascular risk","volume":"40","author":"Cash","year":"2010","journal-title":"Hepatol Res"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib180","doi-asserted-by":"crossref","first-page":"G764","DOI":"10.1152\/ajpgi.00501.2009","article-title":"Impaired cardiovascular function in primary biliary cirrhosis","volume":"298","author":"Jones","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib181","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1572-0241.2008.01888.x","article-title":"Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis","volume":"103","author":"Floreani","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib182","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00508-012-0162-9","article-title":"Assessment of metabolic syndrome in patients with primary biliary cirrhosis","volume":"124","author":"Alempijevic","year":"2012","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib183","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/01.ATV.0000178994.21828.a7","article-title":"The farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism","volume":"25","author":"Claudel","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib184","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.dld.2012.07.001","article-title":"Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease","volume":"44","author":"Gabbi","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib185","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0022-2275(20)31668-0","article-title":"Cholesterol metabolism in primary biliary cirrhosis during simvastatin and UDCA administration","volume":"42","author":"Del Puppo","year":"2001","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib186","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0168-8278(02)00006-5","article-title":"Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers","volume":"36","author":"Ritzel","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib187","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.21741","article-title":"Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid","volume":"46","author":"Stojakovic","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib188","article-title":"Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid","author":"Honda","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib189","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.atherosclerosis.2009.08.052","article-title":"Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment","volume":"209","author":"Stojakovic","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-511X-5-4","article-title":"Influence of liver cancer on lipid and lipoprotein metabolism","volume":"5","author":"Jiang","year":"2006","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib191","first-page":"25","article-title":"Mechanisms and significance of lipoprotein(a) in hepatocellular carcinoma","volume":"8","author":"Jiang","year":"2009","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib192","first-page":"3","article-title":"Cytokines as positive and negative regulators of tumor promotion and progression","volume":"3","author":"Michiel","year":"1992","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib193","first-page":"1572","article-title":"Acute dyslipoproteinemia induced by interleukin-2: lecithin:cholesteryl acyltransferase, lipoprotein lipase, and hepatic lipase deficiencies","volume":"82","author":"Kwong","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib194","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0022-2275(20)32546-3","article-title":"Regulation of microsomal triglyceride transfer protein mRNA expression by endotoxin and cytokines","volume":"39","author":"Navasa","year":"1998","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib195","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.atherosclerosis.2004.05.020","article-title":"Inhibitory activity of diacylglycerol acyltransferase (DGAT) and microsomal triglyceride transfer protein (MTP) by the flavonoid, taxifolin, in HepG2 cells: potential role in the regulation of apolipoprotein B secretion","volume":"176","author":"Casaschi","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib196","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace","volume":"56","author":"Baffy","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib197","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.1572-0241.2007.01337.x","article-title":"Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century","volume":"102","author":"Capocaccia","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib198","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/lt.500020405","article-title":"Morbidity in patients with posttransplant diabetes mellitus following orthotopic liver transplantation","volume":"2","author":"Trail","year":"1996","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib199","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1053\/jlts.2002.34638","article-title":"Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus","volume":"8","author":"John","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib200","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1111\/j.1600-6143.2006.01408.x","article-title":"The impact of diabetes mellitus on fibrosis progression in patients transplanted for hepatitis C","volume":"6","author":"Foxton","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib201","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2174\/157339913804143234","article-title":"New-onset diabetes mellitus: predictive factors and impact on the outcome of patients undergoing liver transplantation","volume":"9","author":"Sarno","year":"2013","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib202","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0168-8278(96)80329-1","article-title":"Diabetes mellitus after liver transplantation: prevalence and predictive factors","volume":"25","author":"Navasa","year":"1996","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib203","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/lt.20092","article-title":"New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection","volume":"10","author":"Khalili","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib204","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/lt.21010","article-title":"Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection: an observational multicenter study","volume":"13","author":"Saliba","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.atherosclerosis.2013.10.030_bib205","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.clinre.2011.03.008","article-title":"Regression of new-onset diabetes mellitus after conversion from tacrolimus to cyclosporine in liver transplant patients: results of a pilot study","volume":"35","author":"Lorho","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013006308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013006308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T07:34:55Z","timestamp":1716104095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915013006308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":205,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0021915013006308"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.10.030","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.10.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}